Clearity in the News: Help Us Spread the Word!
In conjunction with last week's BIO convention, a Clearity article was featured in the Big Ideas & Innovation, Healthcare, Pharmaceutical sections of LinkedIn's special coverage of the convention. With 3,000 clicks already, this coverage is helping us spread the word about Clearity's work to support women with ovarian cancer in accessing the latest research and data to identify more promising treatment options.
The article, titled "This Isn't Your Grandmother's Ovarian Cancer" focuses on the impact of a recent decision by the U.S. Food and Drug Administration to approve a cancer drug for patients whose tumors are defined by a specific genetic feature (biomarker), rather than by the location in the body where the cancer originated. This decision is encouraging especially for the work being done at The Clearity Foundation, where our focus is improving treatment decision-making for patients with ovarian cancer.
Please click the button below to read and share with your network!